Clinical Trial Update: Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD). [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating patient satisfaction with a metered-dose inhaler with counter in asthma and chronic obstructive pulmonary disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED